Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$131.87
-1.10%
Mkt Cap $7.34B
Analyst Ratings
Buy
13
Hold
1
Sell
0
Price Target (18 analysts)
$183.00
Range $160.00 – $200.00
Implied Upside
+38.8%
Consensus $183.00 vs current $131.87